Your browser doesn't support javascript.
loading
EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.
Sluter, Madison N; Hou, Ruida; Li, Lexiao; Yasmen, Nelufar; Yu, Ying; Liu, Jiawang; Jiang, Jianxiong.
Afiliação
  • Sluter MN; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
  • Hou R; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
  • Li L; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
  • Yasmen N; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
  • Yu Y; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
  • Liu J; Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
  • Jiang J; Medicinal Chemistry Core, Office of Research, University of Tennessee Health Science Center, Memphis, Tennessee 38163, United States.
J Med Chem ; 64(16): 11816-11836, 2021 08 26.
Article em En | MEDLINE | ID: mdl-34352171

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Prostaglandina E Subtipo EP2 / Anti-Inflamatórios Limite: Animals / Humans Idioma: En Revista: J Med Chem Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Prostaglandina E Subtipo EP2 / Anti-Inflamatórios Limite: Animals / Humans Idioma: En Revista: J Med Chem Ano de publicação: 2021 Tipo de documento: Article